BOCA RATON, Fla. - Sensus Healthcare Inc. (NASDAQ:SRTS) announced the introduction of Sensus Link, a cloud-based software solution for its SRT-100 superficial radiotherapy systems, according to a ...

SkinCure Oncology, the industry leader in providing a comprehensive cancer center model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of ...

New financing program provides a "one-stop" pathway for practices to acquire systems through outright purchase or several attractive leasing alternatives Supports improved conversion of late-stage ...

In a prospective observational study of a monocentric trial, the combination of stereotactic radiotherapy or radiosurgery (SRT/SRS) with immunotherapy or targeted therapy demonstrated a local control ...

Supports improved unit economics and expands Sensus’ ability to serve Fair Deal Agreement customers and those who purchase a system BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: ...

See how Specialists in Dermatology in The Woodlands and Houston achieves a 99% skin cancer cure rate with Mohs surgery.

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, ...

Betterness today introduced the Betterness MCP, an agentic Model Context Protocol designed to allow AI systems to interact with real-world health and wellness ...

Detailed price information for Sensus Healthcare Inc (SRTS-Q) from The Globe and Mail including charting and trades.

Memorial Healthcare Friday hosted a ribbon-cutting ceremony and unveiled new signage to celebrate the installation of an ...

US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...